CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Trial of PT2977 in Combination With Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03634540
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:02.119982+00:00
- Published At
- 2024-12-20T00:00:00+00:00
- Record Updated At
- 2024-12-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Renal Cell Carcinoma (RCC)", "Clear Cell Renal Cell Carcinoma (ccRCC)", "Kidney Cancer", "Renal Cancer", "Renal Cell Carcinoma", "Renal Cell Cancer Metastatic", "Renal Cell Carcinoma Recurrent", "Renal Cell Cancer, Recurrent", "Kidney"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-20"- protocolSection.identificationModule.nctId
"NCT03634540"- protocolSection.identificationModule.officialTitle
"A Phase 2 Trial of PT2977 in Combination With Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.